Dalacin C may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
UK matches:
- Dalacin C Capsules 75mg
- Dalacin C Capsules 75mg and 150mg (SPC)
- Dalacin C Phosphate (SPC)
Ingredient matches for Dalacin C
Clindamycin
Clindamycin is reported as an ingredient of Dalacin C in the following countries:
- Czech Republic
- Portugal
- Romania
Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Dalacin C in the following countries:
- Australia
- Belgium
- Bosnia & Herzegowina
- Brazil
- Bulgaria
- Colombia
- Costa Rica
- Croatia (Hrvatska)
- Czech Republic
- Ethiopia
- Georgia
- Greece
- Guatemala
- Honduras
- Hong Kong
- Israel
- Luxembourg
- Mexico
- Netherlands
- Nicaragua
- Panama
- Philippines
- Poland
- Romania
- Singapore
- Switzerland
- Thailand
- United Kingdom
- Vietnam
Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Dalacin C in the following countries:
- Australia
- Austria
- Bahrain
- Belgium
- Bosnia & Herzegowina
- Brazil
- Bulgaria
- Canada
- Chile
- Costa Rica
- Croatia (Hrvatska)
- Czech Republic
- Ecuador
- El Salvador
- Ghana
- Greece
- Guatemala
- Honduras
- Hong Kong
- Hungary
- Ireland
- Israel
- Italy
- Kenya
- Liberia
- Lithuania
- Luxembourg
- Mexico
- Myanmar
- Netherlands
- New Zealand
- Nicaragua
- Panama
- Philippines
- Poland
- Sierra Leone
- Singapore
- Slovakia
- Switzerland
- Tanzania
- Thailand
- Uganda
- United Kingdom
- Vietnam
- Zimbabwe
Clindamycin palmitate hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Dalacin C in the following countries:
- Austria
- Belgium
- Canada
- Costa Rica
- El Salvador
- Guatemala
- Honduras
- Luxembourg
- Mexico
- Netherlands
- Nicaragua
- Panama
- Peru
- Philippines
- Slovakia
- Switzerland
- Vietnam
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment